INVESCO GLOBAL HEALTH SCIENCES FUND
NSAR-B, EX-27, 2000-12-20
Previous: INVESCO GLOBAL HEALTH SCIENCES FUND, NSAR-B, 2000-12-20
Next: INVESCO GLOBAL HEALTH SCIENCES FUND, NSAR-B, EX-99, 2000-12-20



<TABLE> <S> <C>

<ARTICLE> 6
<CIK> 0000880968
<NAME> INVESCO GLOBAL HEALTH SCIENCES FUND

<S>                             <C>
<PERIOD-TYPE>                   YEAR
<FISCAL-YEAR-END>                          OCT-31-2000
<PERIOD-END>                               OCT-31-2000
<INVESTMENTS-AT-COST>                      679,337,626
<INVESTMENTS-AT-VALUE>                     956,724,848
<RECEIVABLES>                               54,118,890
<ASSETS-OTHER>                                 158,071
<OTHER-ITEMS-ASSETS>                             3,260
<TOTAL-ASSETS>                           1,011,005,069
<PAYABLE-FOR-SECURITIES>                    45,245,015
<SENIOR-LONG-TERM-DEBT>                              0
<OTHER-ITEMS-LIABILITIES>                   27,265,865
<TOTAL-LIABILITIES>                         72,510,880
<SENIOR-EQUITY>                                      0
<PAID-IN-CAPITAL-COMMON>                   557,015,204
<SHARES-COMMON-STOCK>                       38,705,515
<SHARES-COMMON-PRIOR>                       37,757,644
<ACCUMULATED-NII-CURRENT>                     (85,099)
<OVERDISTRIBUTION-NII>                               0
<ACCUMULATED-NET-GAINS>                    102,827,628
<OVERDISTRIBUTION-GAINS>                             0
<ACCUM-APPREC-OR-DEPREC>                   278,736,456
<NET-ASSETS>                               938,494,189
<DIVIDEND-INCOME>                            2,774,817
<INTEREST-INCOME>                            1,523,503
<OTHER-INCOME>                                (31,353)
<EXPENSES-NET>                               9,193,828
<NET-INVESTMENT-INCOME>                    (4,926,861)
<REALIZED-GAINS-CURRENT>                   170,794,007
<APPREC-INCREASE-CURRENT>                  173,930,690
<NET-CHANGE-FROM-OPS>                      344,724,697
<EQUALIZATION>                                       0
<DISTRIBUTIONS-OF-INCOME>                    2,654,362
<DISTRIBUTIONS-OF-GAINS>                    89,653,448
<DISTRIBUTIONS-OTHER>                                0
<NUMBER-OF-SHARES-SOLD>                              0
<NUMBER-OF-SHARES-REDEEMED>                          0
<SHARES-REINVESTED>                            947,871
<NET-CHANGE-IN-ASSETS>                     260,464,011
<ACCUMULATED-NII-PRIOR>                        920,686
<ACCUMULATED-GAINS-PRIOR>                   28,348,840
<OVERDISTRIB-NII-PRIOR>                              0
<OVERDIST-NET-GAINS-PRIOR>                           0
<GROSS-ADVISORY-FEES>                        7,683,110
<INTEREST-EXPENSE>                                   0
<GROSS-EXPENSE>                              9,250,468
<AVERAGE-NET-ASSETS>                       803,359,189
<PER-SHARE-NAV-BEGIN>                            17.96
<PER-SHARE-NII>                                 (0.13)
<PER-SHARE-GAIN-APPREC>                           8.83
<PER-SHARE-DIVIDEND>                              0.07
<PER-SHARE-DISTRIBUTIONS>                         2.34
<RETURNS-OF-CAPITAL>                              0.00
<PER-SHARE-NAV-END>                              24.25
<EXPENSE-RATIO>                                   0.01


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission